Management of Localized and Locally Advanced Disease: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 124: | Line 124: | ||
*#*** 26% of RFA and 7% of cryoablation patients did not undergo biopsy | *#*** 26% of RFA and 7% of cryoablation patients did not undergo biopsy | ||
*#*** 3-year local recurrence-free survival rates were 98% for partial nephrectomy, RFA, and cryoablation. | *#*** 3-year local recurrence-free survival rates were 98% for partial nephrectomy, RFA, and cryoablation. | ||
*#** | *#** [https://pubmed.ncbi.nlm.nih.gov/25108580/ Thompson, R. Houston, et al. "Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses." ''European urology'' 67.2 (2015): 252-259.] | ||
*#* Reported rates of local recurrence after TA may represent underestimates because ≈20% of small renal masses are benign rather than RCC, and a pretreatment biopsy has not always been performed. | *#* Reported rates of local recurrence after TA may represent underestimates because ≈20% of small renal masses are benign rather than RCC, and a pretreatment biopsy has not always been performed. | ||